Contingent screening for Down syndrome—results from the FaSTER trial

Comparison of contingent, step‐wise and integrated screening policies.

[1]  R. Galen,et al.  Meta-analysis of first trimester Down syndrome screening studies: free beta-human chorionic gonadotropin significantly outperforms intact human chorionic gonadotropin in a multimarker protocol. , 2007, American journal of obstetrics and gynecology.

[2]  C. Rodeck,et al.  OC14: Integrated screening for Down syndrome in routine clinical practice , 2006 .

[3]  H. Cuckle,et al.  Predicting the result of additional second‐trimester markers from a woman's first‐trimester marker profile: a new concept in Down syndrome screening , 2005, Prenatal Diagnosis.

[4]  J. Haddow,et al.  Integrated serum screening for Down syndrome in primary obstetric practice , 2005, Prenatal diagnosis.

[5]  A. Rudnicka,et al.  First-trimester or second-trimester screening, or both, for Down's syndrome. , 2005, The New England journal of medicine.

[6]  H. Cuckle,et al.  Down syndrome screening in the first and/or second trimester: model predicted performance using meta-analysis parameters. , 2005, Seminars in perinatology.

[7]  H. Cuckle,et al.  Practical strategies in contingent sequential screening for Down syndrome , 2005, Prenatal diagnosis.

[8]  K. Ritchie,et al.  Contingent screening for Down syndrome is an efficient alternative to non‐disclosure sequential screening , 2004, Prenatal diagnosis.

[9]  A. Mackinson,et al.  First and Second Trimester Antenatal Screening for Down's Syndrome: The Results of the Serum, Urine and Ultrasound Screening Study (SURUSS) , 2003, Journal of medical screening.

[10]  N J Wald,et al.  First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). , 2003, Health technology assessment.

[11]  M. Christiansen,et al.  An increase in cost‐effectiveness of first trimester maternal screening programmes for fetal chromosome anomalies is obtained by contingent testing , 2002, Prenatal diagnosis.

[12]  A. Herman,et al.  Comparison between disclosure and non-disclosure approaches for trisomy 21 screening tests. , 2002, Human reproduction.

[13]  H. Cuckle.  Integrating antenatal Down's syndrome screening , 2001, Current opinion in obstetrics & gynecology.

[14]  H. Cuckle,et al.  Appropriate biochemical parameters in first‐trimester screening for Down syndrome , 1999, Prenatal diagnosis.

[15]  H. Cuckle.  Improved parameters for risk estimation in Down's syndrome screening , 1995, Prenatal diagnosis.

[16]  H. Cuckle,et al.  Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha‐fetoprotein level , 1987, British journal of obstetrics and gynaecology.